Sarepta Therapeutics Inc (SRPT)

Exchange
NASDAQ
Symbol
SRPT
Sector
Life Sciences
Industry
Pharmaceutical Preparations
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapies, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. The company is headquartered in Cambridge, Massachusetts.
Country
USA

Stock price

At close: March 7, 2025

  • Open
    104.02
  • High
    104.85
  • Low
    102.00
  • Close
    103.03
  • Volume
    1,159,970

Financial ratios

Mar 31, 2024